Search Results 101-110 of 18476 for total bilirubin

  1. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

    Have total bilirubin <2.0 mg/dL; Have aspartate aminotransferase and alanine aminotransferase <3 times the upper limit of normal; Have serum creatinine ≤3 ...

  2. Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia - Mayo Clinic

    Total serum IgG 2.0 × ULN;; Total bilirubin level > 1.5 × ULN; participants with a history of Gilbert's syndrome may have direct bilirubin measured and would ...

  3. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

    ... total serum bilirubin > 1.5 x ULN (patients with Gilbert's Disease may be included if their total bilirubin is ≤3.0 mg/dL); Renal: Creatinine > 1.5x ULN ...

  4. A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495) - Mayo Clinic

    Total bilirubin ≤.5 ×ULN OR direct bilirubin ≤LN for participants with total bilirubin levels >1.5 × ULN;; AST (SGOT) and ALT (SGPT) ≤.5 × ULN ...

  5. Study of HPN536 in Patients with Advanced Cancers Associated With Mesothelin Expression - Mayo Clinic

    Total serum bilirubin ≤ 1.5 x upper limit of normal (ULN) unless the patient has documented Gilbert syndrome in which case the maximum total serum ...

  6. A Study Comparing Combinations of Chemotherapy for Treating Women who have Undergone Surgery for Node-Positive Breast Cancer - Mayo Clinic

    Postoperative evidence of adequate hepatic function must be met. Total bilirubin must be less than or equal to ULN for the lab unless has a grade 1 bilirubin ...

  7. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

    Participation eligibility · Total bilirubin ≤ 1.5 x upper limit of normal (ULN) unless due to Gilbert's disease: · Must have failed or be unable to tolerate or ...

  8. Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma - Mayo Clinic

    ... Total bilirubin =< 1.5 x upper limit of normal (ULN) (within 28 days prior to step 1 registration) - Aspartate aminotransferase (AST) and alanine ...

  9. Pazopanib Hydrochloride in Treating Patients with Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma - Mayo Clinic

    Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) (except in cases of Gilbert's syndrome, where indirect bilirubin may be elevated, but the ...

  10. A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor - Mayo Clinic

    - Age: >= 16 years; Maximum serum creatinine (mg/dL): 1.7 male; 1.4 female - Total bilirubin =< 1.5 x upper limit of normal (ULN) for age - Serum glutamate ...